|
Mechanismβ-lactamase inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Livzon Syntpharm Co. Ltd. Zhuhai Ftz
0 Patents (Medical) associated with Livzon Syntpharm Co. Ltd. Zhuhai Ftz
100 Deals associated with Livzon Syntpharm Co. Ltd. Zhuhai Ftz
100 Translational Medicine associated with Livzon Syntpharm Co. Ltd. Zhuhai Ftz